Breast cancer subtypes affect the ultrasound performance for axillary lymph node status evaluation after neoadjuvant chemotherapy: a retrospective analysis

ConclusionThe diagnostic value of axillary ultrasound for node residue disease assessment after neoadjuvant chemotherapy is different between four breast cancer subtypes.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research